BioNTech SE vs LabGenius Therapeutics
BioNTech SE
Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases
5157 employees · est. 2008 · Mainz, Germany
LabGenius Therapeutics
Combining human and machine intelligence to discover the next generation of therapeutic antibodies
63 employees · est. 2012 · London, United Kingdom
BioNTech SE is the older company (2008 vs 2012); BioNTech SE is the larger of the two.
Side-by-Side Comparison
| Metric | BioNTech SE | LabGenius Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2008 older | 2012 |
| Headquarters | ||
| Headquarters | Mainz, Germany | London, United Kingdom |
| Employees | ||
| Employees | 5157 larger | 63 |
| Industry | ||
| Industry | Health Care | AI, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Series B |
| Total Funding | ||
| Total Funding | Not tracked yet | $63.66M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 6 |
| Services | ||
| Services | Development of immunotherapies, mRNA vaccine development, Oncology treatment advancement, Research & Innovation | Therapeutic Antibody Discovery, Multispecific Antibody Development, AI and Machine Learning Integration |
| Target Customers | ||
| Target Customers | Cancer patients, Medical professionals, Healthcare institutions, Research collaborators | Pharmaceutical Companies, Biotech Research Organizations, Healthcare Providers |
| Taxonomy | ||
| Taxonomy | ImmunotherapyMRNA TherapeuticsOncologyIndividualized Cancer MedicinePatient-specific ImmunotherapyCAR T Cells +7 | Therapeutic AntibodiesDrug DiscoveryRobotic AutomationSynthetic BiologyProtein TherapeuticsAntibody Engineering +6 |
| Website | ||
| Website | biontech.de | labgeniustx.com |
About BioNTech SE
BioNTech SE, founded in 2008 and headquartered in Germany, is a distinguished player in the Health Care industry, aiming to leverage the immune system for novel therapies against cancer and infectious diseases. With a workforce of approximately 6,100, BioNTech is notable for its extensive computatio...
About LabGenius Therapeutics
LabGenius Therapeutics, founded in 2012, is a drug discovery company based in the United Kingdom. It focuses on the development of next-generation therapeutic antibodies utilizing its advanced EVA™ platform, which combines artificial intelligence, robotic automation, and synthetic biology. This plat...
Also comparing in this category
Comparing more than these two?
Get BioNTech SE, LabGenius Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does BioNTech SE compare?
A PDF of BioNTech SE and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare BioNTech SE with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at BioNTech SE on 19 Jun 2026, and LabGenius Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
